Spark 'very encouraged' by gene therapy data, targets 2021 for pivotal study
July 13, 2020 at 12:12 PM EDT
The company's goal is to produce a hemophilia A gene therapy that demonstrates "safety, predictability, efficacy, and durability."
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|